Holdings (Monthly)
Guide ↗
Direxion Daily S&P Biotech Bull 3X Shares
· Direxion Shares ETF Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | N/A | Apr 2024 | 130,597,666 | $130.6M | 22.66% | STIV |
| 2 | GOLDMAN FINANCIAL | N/A | Apr 2024 | 97,690,016 | $97.7M | 16.95% | STIV |
| 3 | GOLDMAN SACHS LIQ ES FD A | N/A | Apr 2024 | 63,891,150 | $63.9M | 11.09% | STIV |
| 4 | N/A | N/A | Apr 2024 | 1 | $7.4M | 1.28% | DE |
| 5 | N/A | N/A | Apr 2024 | 1 | $6.2M | 1.08% | DE |
| 6 | Moderna Inc | MRNA | Apr 2024 | 132,942 | $5.9M | 1.02% | EC |
| 7 | Mirum Pharmaceuticals Inc. | MIRM | Apr 2024 | 48,393 | $5.0M | 0.87% | EC |
| 8 | Revolution Medicines Inc | RVMD | Apr 2024 | 49,557 | $4.8M | 0.83% | EC |
| 9 | Vaxcyte Inc | PCVX | Apr 2024 | 88,740 | $4.8M | 0.82% | EC |
| 10 | Amicus Therapeutics Inc. | FOLD | Apr 2024 | 327,119 | $4.7M | 0.81% | EC |
| 11 | Praxis Precision Medicines Inc | PRAX UW | Apr 2025 | 14,755 | $4.6M | 0.80% | EC |
| 12 | Alkermes PLC | ALKS | Apr 2024 | 134,848 | $4.6M | 0.79% | EC |
| 13 | Gilead Sciences Inc. | GILD | Apr 2024 | 31,805 | $4.5M | 0.78% | EC |
| 14 | Krystal Biotech Inc | KRYS | Apr 2024 | 16,099 | $4.5M | 0.78% | EC |
| 15 | Halozyme Therapeutics Inc | HALO | Apr 2024 | 61,600 | $4.4M | 0.77% | EC |
| 16 | Amgen Inc. | AMGN | Apr 2024 | 12,238 | $4.2M | 0.73% | EC |
| 17 | Celcuity Inc. | CELC | Jan 2026 | 37,898 | $4.1M | 0.72% | EC |
| 18 | Roivant Sciences Ltd | ROIV | Apr 2024 | 190,679 | $4.1M | 0.72% | EC |
| 19 | Bridgebio Pharma Inc | BBIO | Apr 2024 | 53,085 | $4.1M | 0.71% | EC |
| 20 | Vertex Pharmaceuticals Incorporated | VRTX | Apr 2024 | 8,678 | $4.1M | 0.71% | EC |
| 21 | Biomarin Pharmaceutical Inc. | BMRN | Apr 2024 | 71,868 | $4.1M | 0.71% | EC |
| 22 | Incyte Corporation. | INCY | Apr 2024 | 40,550 | $4.1M | 0.70% | EC |
| 23 | Ionis Pharmaceuticals, Inc. | IONS | Apr 2024 | 49,083 | $4.1M | 0.70% | EC |
| 24 | Cytokinetics Inc | CYTK | Apr 2024 | 64,030 | $4.0M | 0.70% | EC |
| 25 | GRAIL Inc | GRAL | Apr 2025 | 40,655 | $4.0M | 0.69% | EC |
| 26 | Regeneron Pharmaceuticals, Inc. | REGN | Apr 2024 | 5,313 | $3.9M | 0.68% | EC |
| 27 | PTC Therapeutics, Inc. | PTCT | Apr 2024 | 52,082 | $3.9M | 0.68% | EC |
| 28 | Avidity Biosciences Inc. | RNA | Apr 2024 | 54,090 | $3.9M | 0.68% | EC |
| 29 | Biogen Inc | BIIB | Apr 2024 | 21,734 | $3.9M | 0.68% | EC |
| 30 | Exact Sciences Corporation | EXAS | Apr 2024 | 38,118 | $3.9M | 0.68% | EC |
| 31 | Exelixis, Inc. | EXEL | Apr 2024 | 93,970 | $3.9M | 0.67% | EC |
| 32 | Arrowhead Pharmaceuticals Inc | ARWR | Apr 2024 | 56,037 | $3.9M | 0.67% | EC |
| 33 | Natera Inc. | NTRA | Apr 2024 | 16,553 | $3.8M | 0.66% | EC |
| 34 | AbbVie Inc. | ABBV | Apr 2024 | 17,141 | $3.8M | 0.66% | EC |
| 35 | Scholar Rock Holding Corp. | SRRK | Apr 2024 | 85,666 | $3.8M | 0.66% | EC |
| 36 | Rhythm Pharmaceuticals Inc | RYTM | Apr 2024 | 36,836 | $3.8M | 0.66% | EC |
| 37 | United Therapeutics Corporation | UTHR | Apr 2024 | 7,959 | $3.7M | 0.65% | EC |
| 38 | TG Therapeutics Inc | TGTX | Apr 2024 | 126,120 | $3.7M | 0.64% | EC |
| 39 | CG Oncology Inc. | CGON | Apr 2025 | 70,357 | $3.7M | 0.64% | EC |
| 40 | Travere Therapeutics Inc | TVTX | Apr 2024 | 112,254 | $3.5M | 0.61% | EC |
| 41 | Protagonist Therapeutics Inc | PTGX | Apr 2024 | 42,231 | $3.5M | 0.60% | EC |
| 42 | Madrigal Pharmaceuticals Inc | MDGL | Apr 2024 | 6,985 | $3.4M | 0.59% | EC |
| 43 | Neurocrine Biosciences Inc | NBIX | Apr 2024 | 24,799 | $3.4M | 0.59% | EC |
| 44 | CRISPR Therapeutics AG | CRSP | Apr 2024 | 67,015 | $3.3M | 0.58% | EC |
| 45 | Adma Biologics Inc | ADMA | Apr 2024 | 193,157 | $3.3M | 0.58% | EC |
| 46 | Acadia Pharmaceuticals Inc | ACAD | Apr 2024 | 131,529 | $3.3M | 0.57% | EC |
| 47 | Beam Therapeutics Inc. | BEAM | Apr 2024 | 117,327 | $3.2M | 0.56% | EC |
| 48 | Alnylam Pharmaceuticals Inc. | ALNY | Apr 2024 | 9,543 | $3.2M | 0.56% | EC |
| 49 | Insmed Inc | INSM | Apr 2024 | 20,328 | $3.2M | 0.55% | EC |
| 50 | Arcellx Inc | ACLX | Apr 2024 | 46,116 | $3.2M | 0.55% | EC |
| 51 | Nuvalent Inc | NUVL | Apr 2024 | 30,479 | $3.1M | 0.54% | EC |
| 52 | Twist Bioscience Corporation | TWST | Apr 2024 | 75,800 | $3.1M | 0.54% | EC |
| 53 | Viking Therapeutics Inc. | VKTX | Apr 2024 | 102,836 | $3.0M | 0.52% | EC |
| 54 | Arcutis Biotherapeutics Inc. | ARQT | Apr 2024 | 114,150 | $2.9M | 0.50% | EC |
| 55 | Kymera Therapeutics Inc | KYMR | Apr 2024 | 38,912 | $2.8M | 0.49% | EC |
| 56 | Dyne Therapeutics Inc. | DYN | Apr 2024 | 155,127 | $2.8M | 0.48% | EC |
| 57 | Summit Therapeutics Inc. | SMMT | Apr 2024 | 190,936 | $2.8M | 0.48% | EC |
| 58 | Denali Therapeutics Inc | DNLI | Apr 2024 | 127,089 | $2.8M | 0.48% | EC |
| 59 | IDEAYA Biosciences Inc. | IDYA | Apr 2024 | 83,830 | $2.7M | 0.47% | EC |
| 60 | Recursion Pharmaceuticals Inc | RXRX | Apr 2024 | 642,720 | $2.7M | 0.47% | EC |
| 61 | Cogent Biosciences Inc. | COGT | Apr 2024 | 73,699 | $2.6M | 0.46% | EC |
| 62 | Sarepta Therapeutics Inc | SRPT | Apr 2024 | 129,535 | $2.6M | 0.46% | EC |
| 63 | Mineralys Therapeutics Inc. | MLYS | Jan 2026 | 84,862 | $2.6M | 0.45% | EC |
| 64 | Apellis Pharmaceuticals Inc | APLS | Apr 2024 | 113,746 | $2.6M | 0.45% | EC |
| 65 | ImmunityBio Inc | IBRX | Apr 2024 | 402,904 | $2.5M | 0.44% | EC |
| 66 | Ultragenyx Pharmaceuticals Inc | RARE | Apr 2024 | 104,196 | $2.5M | 0.44% | EC |
| 67 | Catalyst Pharmaceuticals Inc. | CPRX | Apr 2024 | 102,851 | $2.5M | 0.43% | EC |
| 68 | Uniqure N.V. | QURE | Apr 2025 | 109,420 | $2.5M | 0.43% | EC |
| 69 | Vera Therapeutics Inc. | VERA | Apr 2024 | 56,947 | $2.5M | 0.43% | EC |
| 70 | Soleno Therapeutics Inc | SLNO UR | Apr 2024 | 63,418 | $2.4M | 0.42% | EC |
| 71 | Immunovant Inc | IMVT | Apr 2024 | 87,798 | $2.3M | 0.40% | EC |
| 72 | Viridian Therapeutics Inc | VRDN | Apr 2024 | 66,174 | $2.2M | 0.38% | EC |
| 73 | Syndax Pharmaceuticals Inc. | SNDX | Apr 2024 | 107,435 | $2.2M | 0.38% | EC |
| 74 | Veracyte Inc | VCYT | Apr 2024 | 57,293 | $2.2M | 0.38% | EC |
| 75 | Apogee Therapeutics Inc. | APGE | Apr 2024 | 32,253 | $2.1M | 0.37% | EC |
| 76 | Dianthus Therapeutics Inc | DNTH | Apr 2025 | 38,394 | $2.0M | 0.36% | EC |
| 77 | Ardelyx Inc | ARDX | Apr 2024 | 258,872 | $2.0M | 0.35% | EC |
| 78 | Agios Pharmaceuticals Inc | AGIO | Apr 2024 | 71,309 | $2.0M | 0.34% | EC |
| 79 | Novavax Inc | NVAX | Apr 2024 | 218,583 | $1.9M | 0.34% | EC |
| 80 | Dynavax Technologies Corp. | DVAX | Apr 2024 | 122,012 | $1.9M | 0.33% | EC |
| 81 | Intellia Therapeutics Inc | NTLA | Apr 2024 | 142,915 | $1.9M | 0.33% | EC |
| 82 | Celldex Therapeutics Inc. | CLDX | Apr 2024 | 75,780 | $1.9M | 0.32% | EC |
| 83 | Immunome Inc | IMNM | Apr 2025 | 75,227 | $1.9M | 0.32% | EC |
| 84 | Disc Medicine Inc | IRON | Apr 2024 | 23,945 | $1.9M | 0.32% | EC |
| 85 | Stoke Therapeutics Inc | STOK | Apr 2025 | 59,836 | $1.8M | 0.31% | EC |
| 86 | Vericel Corporation | VCEL | Apr 2024 | 50,153 | $1.8M | 0.31% | EC |
| 87 | Tango Therapeutics Inc. | TNGX | Jan 2026 | 150,328 | $1.7M | 0.30% | EC |
| 88 | Mannkind Corporation | MNKD | Apr 2024 | 300,173 | $1.7M | 0.30% | EC |
| 89 | N/A | N/A | Apr 2024 | 1 | $1.7M | 0.30% | DE |
| 90 | BioCryst Pharmaceuticals Inc. | BCRX | Apr 2024 | 253,788 | $1.7M | 0.29% | EC |
| 91 | Biohaven Ltd | BHVN | Apr 2024 | 138,856 | $1.6M | 0.29% | EC |
| 92 | Janux Therapeutics Inc | JANX | Apr 2025 | 116,259 | $1.6M | 0.28% | EC |
| 93 | N/A | N/A | Apr 2024 | 1 | $1.5M | 0.26% | DE |
| 94 | Corvus Pharmaceuticals Inc | CRVS | Jan 2026 | 66,158 | $1.4M | 0.24% | EC |
| 95 | Arcus Biosciences Inc. | RCUS | Apr 2024 | 61,647 | $1.3M | 0.23% | EC |
| 96 | RAPT Therapeutics Inc. | RAPT | Jan 2026 | 21,882 | $1.3M | 0.22% | EC |
| 97 | Caredx Inc | CDNA | Apr 2024 | 60,456 | $1.2M | 0.22% | EC |
| 98 | ORIC Pharmaceuticals Inc. | ORIC | Apr 2024 | 117,540 | $1.2M | 0.21% | EC |
| 99 | Iovance Biotherapeutics Inc | IOVA | Apr 2024 | 468,662 | $1.2M | 0.21% | EC |
| 100 | Day One Biopharmaceuticals Inc. | DAWN | Apr 2024 | 104,161 | $1.2M | 0.20% | EC |
| 101 | Spyre Therapeutics Inc | SYRE | Apr 2025 | 35,436 | $1.1M | 0.20% | EC |
| 102 | Precigen Inc | PGEN | Jan 2026 | 248,246 | $1.1M | 0.19% | EC |
| 103 | AnaptysBio Inc. | ANAB | Apr 2024 | 23,425 | $1.1M | 0.19% | EC |
| 104 | Cytomx Therapeutics Inc | CTMX | Jan 2026 | 181,497 | $1.0M | 0.18% | EC |
| 105 | Taysha Gene Therapies Inc. | TSHA | Jan 2026 | 228,731 | $1.0M | 0.18% | EC |
| 106 | Kura Oncology Inc. | KURA | Apr 2024 | 124,315 | $1.0M | 0.18% | EC |
| 107 | Rigel Pharmaceuticals Inc. | RIGL UW | Apr 2025 | 28,594 | $997K | 0.17% | EC |
| 108 | Nurix Therapeutics Inc. | NRIX | Apr 2024 | 60,047 | $992K | 0.17% | EC |
| 109 | Relay Therapeutics Inc | RLAY | Apr 2024 | 128,537 | $985K | 0.17% | EC |
| 110 | Monte Rosa Therapeutics Inc | GLUE | Jan 2026 | 44,736 | $918K | 0.16% | EC |
| 111 | Erasca Inc | ERAS | Jan 2026 | 86,920 | $914K | 0.16% | EC |
| 112 | Kodiak Sciences Inc | KOD | Jan 2026 | 39,486 | $899K | 0.16% | EC |
| 113 | Oruka Therapeutics Inc | ORKA | Jan 2026 | 25,530 | $874K | 0.15% | EC |
| 114 | Sana Biotechnology Inc | SANA | Apr 2024 | 181,881 | $806K | 0.14% | EC |
| 115 | Palvella Therapeutics Inc. | PVLA | Jan 2026 | 10,439 | $801K | 0.14% | EC |
| 116 | Upstream Bio Inc | UPB | Jan 2026 | 25,665 | $798K | 0.14% | EC |
| 117 | N/A | N/A | Apr 2024 | 1 | $791K | 0.14% | DE |
| 118 | Xencor Inc | XNCR | Apr 2024 | 64,846 | $784K | 0.14% | EC |
| 119 | Olema Pharmaceuticals Inc. | OLMA | Jan 2026 | 29,857 | $768K | 0.13% | EC |
| 120 | ARS Pharmaceuticals Inc | SPRY | Apr 2024 | 76,666 | $766K | 0.13% | EC |
| 121 | Geron Corp. | GERN | Apr 2024 | 545,248 | $747K | 0.13% | EC |
| 122 | Altimmune Inc. | ALT UQ | Apr 2024 | 129,871 | $727K | 0.13% | EC |
| 123 | Sionna Therapeutics Inc. | SION | Jan 2026 | 16,383 | $692K | 0.12% | EC |
| 124 | KalVista Pharmaceuticals Inc. | KALV | Apr 2025 | 43,515 | $679K | 0.12% | EC |
| 125 | Emergent Biosolutions Inc | EBS | Apr 2025 | 59,054 | $670K | 0.12% | EC |
| 126 | Bicara Therapeutics Inc. | BCAX | Jan 2026 | 39,685 | $667K | 0.12% | EC |
| 127 | VIR Biotechnology Inc | VIR | Apr 2024 | 88,740 | $660K | 0.11% | EC |
| 128 | Replimune Group Inc | REPL | Apr 2024 | 93,479 | $657K | 0.11% | EC |
| 129 | Compass Therapeutics Inc | CMPX | Jan 2026 | 100,668 | $644K | 0.11% | EC |
| 130 | Annexon Inc | ANNX | Jan 2026 | 93,969 | $586K | 0.10% | EC |
| 131 | Myriad Genetics Inc. | MYGN | Apr 2024 | 99,001 | $556K | 0.10% | EC |
| 132 | Verastem Inc | VSTM | Jan 2026 | 85,800 | $523K | 0.09% | EC |
| 133 | Lexeo Therapeutics Inc | LXEO | Jan 2026 | 67,774 | $502K | 0.09% | EC |
| 134 | 4D Molecular Therapeutics Inc | FDMT | Jan 2026 | 55,336 | $490K | 0.09% | EC |
| 135 | Cullinan Therapeutics Inc | CGEM | Apr 2024 | 40,913 | $489K | 0.08% | EC |
| 136 | Anavex Life Sciences Corp. | AVXL | Apr 2024 | 103,690 | $487K | 0.08% | EC |
| 137 | Prothena Corporation PLC | PRTA | Apr 2024 | 54,764 | $482K | 0.08% | EC |
| 138 | Prime Medicine Inc | PRME | Jan 2026 | 124,530 | $474K | 0.08% | EC |
| 139 | Gossamer Bio Inc | GOSS | Jan 2026 | 207,515 | $473K | 0.08% | EC |
| 140 | Akebia Therapeutics Inc. | AKBA | Apr 2025 | 330,791 | $466K | 0.08% | EC |
| 141 | Regenxbio Inc. | RGNX | Jan 2026 | 39,274 | $438K | 0.08% | EC |
| 142 | Inhibrx Biosciences Inc. | INBX | Jan 2026 | 5,690 | $434K | 0.08% | EC |
| 143 | ArriVent BioPharma Inc. | AVBP | Apr 2025 | 19,155 | $431K | 0.07% | EC |
| 144 | Absci Corp. | ABSI | Jan 2026 | 135,880 | $406K | 0.07% | EC |
| 145 | Immuneering Corp. | IMRX | Jan 2026 | 86,733 | $402K | 0.07% | EC |
| 146 | Keros Therapeutics Inc. | KROS | Apr 2024 | 20,090 | $360K | 0.06% | EC |
| 147 | Invivyd Inc | IVVD | Jan 2026 | 188,784 | $328K | 0.06% | EC |
| 148 | Savara Inc | SVRA | Jan 2026 | 59,615 | $322K | 0.06% | EC |
| 149 | Arbutus Biopharma Corp. | ABUS | Apr 2025 | 77,640 | $321K | 0.06% | EC |
| 150 | Tyra Biosciences Inc | TYRA | Jan 2026 | 10,255 | $316K | 0.05% | EC |
| 151 | Rezolute Inc | RZLT | Jan 2026 | 92,476 | $309K | 0.05% | EC |
| 152 | MiMedx Group Inc. | MDXG | Apr 2024 | 45,979 | $235K | 0.04% | EC |
| 153 | Ironwood Pharmaceuticals, Inc. | IRWD | Jan 2026 | 43,016 | $210K | 0.04% | EC |
| 154 | N/A | N/A | Apr 2024 | 1 | $173K | 0.03% | DE |
| 155 | NOVOB DC CVR | 009CVR044 | Jan 2026 | 128,720 | $0 | 0.00% | EC |
| 156 | INHIBRX INC CVR | 457CVR017 | Apr 2025 | 164,173 | $0 | 0.00% | EC |
| 157 | OmniAb Inc. | 2200963D | Apr 2024 | 14,783 | $0 | 0.00% | EC |
| 158 | OmniAb Inc. | 2200964D | Apr 2024 | 14,783 | $0 | 0.00% | EC |
| 159 | VERVE THERAPEUTICS INC (CVR) | 925CVR011 | Jan 2026 | 82,531 | $0 | 0.00% | EC |
| 160 | DREYFUS | S99991620 | Apr 2024 | 0 | $0 | 0.00% | STIV |
| 161 | N/A | N/A | Apr 2024 | 1 | $-5767326 | -1.00% | DE |